drugset / Trial / NCT00529789
Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary purpose of your participation in this study is to help answer the following research question, and not to provide you treatment for your condition. Whether duloxetine once daily orally is tolerated and safe, in children (aged 7 through 11 years) and adolescents (aged 12 through 17 years) with Major Depressive Disorder.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 20 mg | Oral |
| Subject | Duloxetine | Small molecule | 120 mg | Oral |